124 related articles for article (PubMed ID: 33886353)
1. Addressing Neurocognitive Late Effects in Pediatric Cancer Survivors: Current Approaches and Future Opportunities.
Hocking MC; Walsh KS; Hardy KK; Conklin HM
J Clin Oncol; 2021 Jun; 39(16):1824-1832. PubMed ID: 33886353
[No Abstract] [Full Text] [Related]
2. Assessment and Monitoring of Neurocognitive Function in Pediatric Cancer.
Jacola LM; Partanen M; Lemiere J; Hudson MM; Thomas S
J Clin Oncol; 2021 Jun; 39(16):1696-1704. PubMed ID: 33886364
[No Abstract] [Full Text] [Related]
3. Biomarkers of Cognitive Impairment in Pediatric Cancer Survivors.
Williams AM; Cole PD
J Clin Oncol; 2021 Jun; 39(16):1766-1774. PubMed ID: 33886369
[No Abstract] [Full Text] [Related]
4. Cognitive Impairment in Survivors of Pediatric Extracranial Solid Tumors and Lymphomas.
Foster R; Zheng DJ; Netson-Amore KL; Kadan-Lottick NS
J Clin Oncol; 2021 Jun; 39(16):1727-1740. PubMed ID: 33886354
[No Abstract] [Full Text] [Related]
5. Life-Altering Consequences of Neurocognitive Impairment in Survivors of Pediatric Cancer.
Hardy KK; Hudson MM; Krull KR
J Clin Oncol; 2021 Jun; 39(16):1693-1695. PubMed ID: 33886347
[No Abstract] [Full Text] [Related]
6. Cognitive Risk in Survivors of Pediatric Brain Tumors.
Oyefiade A; Paltin I; De Luca CR; Hardy KK; Grosshans DR; Chintagumpala M; Mabbott DJ; Kahalley LS
J Clin Oncol; 2021 Jun; 39(16):1718-1726. PubMed ID: 33886348
[No Abstract] [Full Text] [Related]
7. Brain Imaging in Pediatric Cancer Survivors: Correlates of Cognitive Impairment.
Kesler SR; Sleurs C; McDonald BC; Deprez S; van der Plas E; Nieman BJ
J Clin Oncol; 2021 Jun; 39(16):1775-1785. PubMed ID: 33886371
[No Abstract] [Full Text] [Related]
8. Health Behaviors and Neurocognitive Function in Survivors of Childhood Cancer.
Kunin-Batson AS; Klosky JL; Carlson-Green B; Brinkman TM
J Clin Oncol; 2021 Jun; 39(16):1786-1794. PubMed ID: 33886366
[No Abstract] [Full Text] [Related]
9. Cognitive Impairment and Family Functioning of Survivors of Pediatric Cancer: A Systematic Review.
Schepers SA; Schulte FSM; Patel SK; Vannatta K
J Clin Oncol; 2021 Jun; 39(16):1795-1812. PubMed ID: 33886349
[No Abstract] [Full Text] [Related]
10. Cognitive Impairment in Survivors of Pediatric Acute Lymphoblastic Leukemia Treated With Chemotherapy Only.
van der Plas E; Modi AJ; Li CK; Krull KR; Cheung YT
J Clin Oncol; 2021 Jun; 39(16):1705-1717. PubMed ID: 33886368
[No Abstract] [Full Text] [Related]
11. Disseminability of computerized cognitive training: Performance across coaches.
Fournier-Goodnight AS; Ashford JM; Clark KN; Martin-Elbahesh K; Hardy KK; Merchant TE; Jeha S; Ogg RJ; Zhang H; Wang L; Conklin HM
Appl Neuropsychol Child; 2019; 8(2):113-122. PubMed ID: 29161113
[TBL] [Abstract][Full Text] [Related]
12. Association Between Executive Functioning and Functional Impairment Among Pediatric Cancer Survivors and Controls.
Erickson SJ; Hile S; Rieger RE; Moss NC; Dinces S; Annett RD
Arch Clin Neuropsychol; 2019 Jul; 34(5):599-609. PubMed ID: 30307471
[TBL] [Abstract][Full Text] [Related]
13. Cognitive Rehabilitation for Cognitive Dysfunction after Cancer and Cancer Treatment: Implications for Nursing Practice.
Von Ah D; Crouch A
Semin Oncol Nurs; 2020 Feb; 36(1):150977. PubMed ID: 31959511
[TBL] [Abstract][Full Text] [Related]
14. Discrepancies among Measures of Executive Functioning in a Subsample of Young Adult Survivors of Childhood Brain Tumor: Associations with Treatment Intensity.
McCurdy MD; Turner EM; Barakat LP; Hobbie WL; Deatrick JA; Paltin I; Fisher MJ; Hocking MC
J Int Neuropsychol Soc; 2016 Oct; 22(9):900-910. PubMed ID: 27667398
[TBL] [Abstract][Full Text] [Related]
15. Systematic Review of Educational Supports of Pediatric Cancer Survivors: Current Approaches and Future Directions.
Gilleland Marchak J; Devine KA; Hudson MM; Jacobson LA; Michel G; Peterson SR; Schulte F; Wakefield CE; Sands SA
J Clin Oncol; 2021 Jun; 39(16):1813-1823. PubMed ID: 33886350
[No Abstract] [Full Text] [Related]
16. Executive dysfunction is associated with poorer health-related quality of life in pediatric brain tumor survivors.
Netson KL; Ashford JM; Skinner T; Carty L; Wu S; Merchant TE; Conklin HM
J Neurooncol; 2016 Jun; 128(2):313-21. PubMed ID: 27033060
[TBL] [Abstract][Full Text] [Related]
17. Neurotoxic Effects of Childhood Cancer Therapy and Its Potential Neurocognitive Impact.
Phillips NS; Duke ES; Schofield HT; Ullrich NJ
J Clin Oncol; 2021 Jun; 39(16):1752-1765. PubMed ID: 33886374
[No Abstract] [Full Text] [Related]
18. Long-Term Neurocognitive and Psychosocial Outcomes After Acute Myeloid Leukemia: A Childhood Cancer Survivor Study Report.
Stefanski KJ; Anixt JS; Goodman P; Bowers K; Leisenring W; Scott Baker K; Burns K; Howell R; Davies S; Robison LL; Armstrong GT; Krull KR; Recklitis C
J Natl Cancer Inst; 2021 Apr; 113(4):481-495. PubMed ID: 32797189
[TBL] [Abstract][Full Text] [Related]
19. Assessment of cognitive and neural recovery in survivors of pediatric brain tumors in a pilot clinical trial using metformin.
Ayoub R; Ruddy RM; Cox E; Oyefiade A; Derkach D; Laughlin S; Ades-Aron B; Shirzadi Z; Fieremans E; MacIntosh BJ; de Medeiros CB; Skocic J; Bouffet E; Miller FD; Morshead CM; Mabbott DJ
Nat Med; 2020 Aug; 26(8):1285-1294. PubMed ID: 32719487
[TBL] [Abstract][Full Text] [Related]
20. Microstructural white matter alterations associated to neurocognitive deficits in childhood leukemia survivors treated with cranial radiotherapy - a diffusional kurtosis study.
Follin C; Svärd D; van Westen D; Björkman-Burtscher IM; Sundgren PC; Fjalldal S; Lätt J; Nilsson M; Johanson A; Erfurth EM
Acta Oncol; 2019 Jul; 58(7):1021-1028. PubMed ID: 30747019
[No Abstract] [Full Text] [Related]
[Next] [New Search]
